Original Article
Evaluating the efficacy and safety of rivaroxaban as a warfarin alternative in chronic thromboembolic pulmonary hypertension patients undergoing pulmonary endarterectomy: A randomized clinical trial
Saghar Baratia, Hossein Aminia, Zargham Hossein Ahmadib, Alireza Dastanc, Babak Sharif Kashanid, Raha Eskandarid, Farzaneh Dastana,d,
Autor para correspondência
a Department of Clinical Pharmacy, School of Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, Iran
b Lung Transplantation Research Center, National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran
c Ernest and Julio Gallo Management Program, School of Engineering University of California, Merced, United States
d Chronic Respiratory Diseases Research Center, National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran
Lido
2534
Vezesque se leu este artigo
1003
Total PDF
1531
Total HTML
| Ano/Mês | Html | Total | |
|---|---|---|---|
| 2025 6 | 15 | 4 | 19 |
| 2025 5 | 94 | 31 | 125 |
| 2025 4 | 75 | 36 | 111 |
| 2025 3 | 86 | 32 | 118 |
| 2025 2 | 69 | 28 | 97 |
| 2025 1 | 46 | 35 | 81 |
| 2024 12 | 54 | 43 | 97 |
| 2024 11 | 58 | 37 | 95 |
| 2024 10 | 57 | 44 | 101 |
| 2024 9 | 55 | 50 | 105 |
| 2024 8 | 58 | 35 | 93 |
| 2024 7 | 40 | 36 | 76 |
| 2024 6 | 36 | 34 | 70 |
| 2024 5 | 34 | 22 | 56 |
| 2024 4 | 65 | 46 | 111 |
| 2024 3 | 56 | 29 | 85 |
| 2024 2 | 26 | 29 | 55 |
| 2024 1 | 32 | 26 | 58 |
| 2023 12 | 25 | 27 | 52 |
| 2023 11 | 42 | 36 | 78 |
| 2023 10 | 36 | 19 | 55 |
| 2023 9 | 30 | 32 | 62 |
| 2023 8 | 29 | 18 | 47 |
| 2023 7 | 36 | 18 | 54 |
| 2023 6 | 28 | 15 | 43 |
| 2023 5 | 57 | 34 | 91 |
| 2023 4 | 38 | 14 | 52 |
| 2023 3 | 66 | 31 | 97 |
| 2023 2 | 91 | 64 | 155 |
| 2023 1 | 22 | 15 | 37 |
| 2022 12 | 28 | 28 | 56 |
| 2022 11 | 47 | 55 | 102 |
Mostrar tudo
